Consensus Claritev Corporation

Stocks

CTEV

US62548M2098

Business Support Services

Real-time Estimate Cboe BZX 20:40:18 28/08/2026 BST			5-day change	1st Jan Change
38.35 ^USD	-1.11%		+3.03%	-10.18%

08-17	Marpai, Inc. Expands Relationship with Claritev Corporation to Help Reduce Healthcare Costs for Employer Clients	CI
08-12	Claritev Insider Sold Shares Worth $288,677, According to a Recent SEC Filing	MT

Evolution of the Average Target: Claritev Corporation

Evolution of the Target Price: Claritev Corporation

Changes in Analyst Recommendations: Claritev Corporation

8adbf8471a47d5916d612f2aa.OEBawCP4kkflQPtamt7YvRRootr4HE769OKr2TyQ1xI.dhY9q0-b0QyJEIoFwLOXz3I_86-gRQ_XmbCfrEr-kHBaJB-ZQrziBadxzw~0ccc778d276beb4ab19ff95e8679dc52

Analysts' recommendations: Claritev Corporation

05-29	Canaccord Genuity Initiates Claritev at Buy With $32 Price Target	MT
01-12	Guggenheim Initiates Coverage on Claritev With Buy Rating, $43 Price Target	MT
01-09	Wells Fargo Initiates Claritev Corp at Equalweight With $33 Price Target	MT
21/10/25	Claritev Shares Rise After Upgrade From Citigroup	MT
21/10/25	Citigroup Upgrades Claritev to Buy From Neutral, $55 Price Target	MT
29/05/25	Claritev Shares Rise After Upgrade From Piper Sandler	MT
29/05/25	Piper Sandler Upgrades Claritev to Overweight From Neutral, Adjusts Price Target to $44 From $19	MT
26/06/24	Piper Sandler Initiates MultiPlan at Neutral With $2 Price Target	MT
08/03/23	Citigroup Adjusts Price Target on MultiPlan to $1.25 From $2, Keeps Neutral Rating	MT
18/01/23	Barclays Adjusts Price Target on MultiPlan to $1 From $3, Maintains Equal-Weight Rating	MT
13/12/22	Citigroup Downgrades MultiPlan to Neutral From Buy, Cuts Price Target to $2 From $3	MT
16/11/22	Goldman Sachs Adjusts Price Target on MultiPlan to $2.05 From $5.50, Maintains Neutral Rating	MT
09/11/22	Citigroup Adjusts Price Target on MultiPlan to $3 From $6, Maintains Buy Rating	MT
12/07/22	Goldman Sachs Starts MultiPlan at Neutral With $6.50 Price Target	MT
20/12/21	Citigroup Adjusts MultiPlan's Price Target to $7 from $9, Keeps Buy Rating	MT
11/11/21	Barclays Adjusts MultiPlan's Price Target to $6 From $7, Keeps Equal-Weight Rating	MT
20/08/21	MultiPlan : Tigress Research Initiates Coverage of MultiPlan with Buy Rating, $9 Price Target	MT
07/04/21	MultiPlan : B. Riley Starts MultiPlan at Buy with $10 Price Target; Expects Material Revenue, Earnings Growth Ahead	MT
19/03/21	MultiPlan : Barclays Starts MultiPlan at Equalweight with $7 Price Target	MT
16/11/20	MultiPlan : Citigroup Starts MultiPlan at Buy With $10 Price Target	MT

More recommendations

Data Processing Services

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Objective/dr gap
CLARITEV CORPORATION		+18.19%
NEBIUS GROUP	-	+31.22%
KEHUA DATA CO., LTD.		+41.98%
SHANGHAI @HUB CO.,LTD.		+16%
JMDC INC.		+28.34%
SDIC INTELLIGENCE INFORMATION TECHNOLOGY CO., LTD.	-	+56.87%
Average		+32.10%
Weighted average by Cap.		+31.35%